These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 5317010)

  • 1. Inhibitory effect of passive antibody on active immunity induced against rabies by vaccination.
    Wiktor TJ; Lerner RA; Koprowski H
    Bull World Health Organ; 1971; 45(6):747-53. PubMed ID: 5317010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serovaccination by human immune globulin and HDCS-vaccine against rabies.
    Kuwert EK; Werner J; Marcus I; Cabasso VJ
    Dev Biol Stand; 1978; 40():129-36. PubMed ID: 680386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
    Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
    Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects.
    Cabasso VJ; Loofbourow JC; Roby RE; Anuskiewicz W
    Bull World Health Organ; 1971; 45(3):303-15. PubMed ID: 5316911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. II.
    ATANASIU P; BAHMANYAR M; BALTAZARD M; FOX JP; HABEL K; KAPLAN MM; KISSLING RE; KOMAROV A; KOPROWSKI H; LEPINE P; PEREZ GALLARDO F; SCHAEFFER M
    Bull World Health Organ; 1957; 17(6):911-32. PubMed ID: 13511138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4.
    Atanasiu P; Dean DJ; Habel K; Kaplan MM; Koprowski H; Lépine P; Serié C
    Bull World Health Organ; 1967; 36(3):361-5. PubMed ID: 5299668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of vaccination of Asian elephants (Elephas maximus) with monovalent inactivated rabies vaccine.
    Isaza R; Davis RD; Moore SM; Briggs DJ
    Am J Vet Res; 2006 Nov; 67(11):1934-6. PubMed ID: 17078758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-exposure use of human diploid cell culture rabies vaccine.
    Kuwert EK; Marcus I; Werner J; Scheiermann N; Höher PG; Thraenhart O; Hierholzer E; Wiktor TJ; Koprowski H
    Dev Biol Stand; 1976 Dec 13-15; 37():273-86. PubMed ID: 1031689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine.
    Archer BG; Dierks RE
    Bull World Health Organ; 1968; 39(3):407-17. PubMed ID: 5303907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attempts at postexposure active and passive human rabies immunization].
    Keller H; Hauser R; Wandeler A; Steck F
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1857-9. PubMed ID: 73219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isogeneic versus allogeneic antiserum in the prophylaxis of experimental rabies.
    Habel K
    Bull World Health Organ; 1968; 38(3):383-7. PubMed ID: 5302331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response to rabies virus infection and vaccination.
    Johnson N; Cunningham AF; Fooks AR
    Vaccine; 2010 May; 28(23):3896-901. PubMed ID: 20368119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity.
    Suwansrinon K; Wilde H; Benjavongkulchai M; Banjongkasaena U; Lertjarutorn S; Boonchang S; Suttisri R; Khowplod P; Daviratanasilpa S; Sitprija V
    Vaccine; 2006 May; 24(18):3878-80. PubMed ID: 16530893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rabies vaccine inactivated with ethylenimine. Duration of the immunity in dogs].
    Larghi OP; Savy VL; Nebel AE; Rodríguez A
    Rev Argent Microbiol; 1979; 11(3):102-7. PubMed ID: 263180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
    Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
    Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.